Wearable Cardioverter Defibrillators

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cardiology in Review

• Publication date

  2016-11-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1097/CRD.0000000000000120PMID 27548691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2018cited by this paper
• Faculty Opinions recommendation of 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2018cited by this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2018cited by this paper
• Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study

  2017cited by this paper
• Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study

  2017cited by this paper
• 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cited by this paper
• Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death

  2016cited by this paper
• Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association

  2016cited by this paper
• The Wearable Cardioverter Defibrillator in Nonischemic Cardiomyopathy: A US National Database Analysis.

  2016cited by this paper
• Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients: Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)

  2015cited by this paper
• Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction

  2015cited by this paper
• Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis.

  2015cited by this paper
• HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.

  2014cited by this paper
• HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.

  2014cited by this paper
• Council on Cardiovascular and Stroke Nursing.

  2014cited by this paper
• Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function—value of the wearable cardioverter/defibrillator

  2014cited by this paper
• EFFECTIVENESS OF WEARABLE DEFIBRILLATORS: SYSTEMATIC REVIEW AND QUALITY OF EVIDENCE

  2014cited by this paper
• Protection from Outpatient Sudden Cardiac Death following ICD Removal Using a Wearable Cardioverter Defibrillator

  2014cited by this paper
• Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.

  2013cited by this paper
• Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

  2013cited by this paper
• Wearable defibrillators in uninsured patients with newly diagnosed cardiomyopathy or recent revascularization in a community medical center.

  2013cited by this paper
• Early Risk of Mortality After Coronary Artery Revascularization in Patients With Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator

  2013cited by this paper
• Wearable Cardioverter-Defibrillators

  2013cited by this paper
• Wearable defibrillator use in heart failure (WIF): results of a prospective registry

  2012cited by this paper
• Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator.

  2012cited by this paper
• Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.

  2011cited by this paper
• Wearable defibrillator in congenital structural heart disease and inherited arrhythmias.

  2011influential reference
• Evaluation of the effectiveness of a wearable cardioverter defibrillator detection algorithm.

  2010cited by this paper
• The wearable cardioverter-defibrillator: lifesaving attire or "fashion faux pas?".

  2010cited by this paper
• Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD)

  2010influential reference
• Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.

  2010cited by this paper
• Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival.

  2010cited by this paper
• Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA).

  2009cited by this paper
• Defibrillator implantation early after myocardial infarction.

  2009cited by this paper
• Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.

  2008cited by this paper
• Prognostic importance of defibrillator shocks in patients with heart failure.

  2008cited by this paper
• Are Implantable Cardioverter Defibrillator Shocks a Surrogate for Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy?

  2006cited by this paper
• Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators.

  2006cited by this paper
• Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2006cited by this paper
• Heart rhythm considerations in heart transplant candidates and considerations for ventricular assist devices: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006.

  2006cited by this paper
• Dual-Chamber Versus Single-Chamber Detection Enhancements for Implantable Defibrillator Rhythm Diagnosis: The Detect Supraventricular Tachycardia Study

  2006cited by this paper
• Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction

  2005cited by this paper
• Use of a Wearable Defibrillator in Terminating Tachyarrhythmias in Patients at High Risk for Sudden Death:

  2004cited by this paper
• Time Dependence of Mortality Risk and Defibrillator Benefit After Myocardial Infarction

  2004cited by this paper
• Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

  2004cited by this paper
• DEFibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE).

  2003cited by this paper
• Clinical Efficacy of a Wearable Defibrillator in Acutely Terminating Episodes of Ventricular Fibrillation Using Biphasic Shocks

  2003cited by this paper
• Summary of Safety and Effectiveness Data

  2002cited by this paper
• Survival Benefit of the Implantable Cardioverter-Defibrillator in Patients on the Waiting List for Cardiac Transplantation

  2001influential reference
• Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation.

  1998cited by this paper
• ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation).

  1998cited by this paper
• Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery

  1997cited by this paper
• A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

  1997cited by this paper
• Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators.

  1997cited by this paper

• Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature

  2022cites this paper
• High Resting Heart Rates Are Associated with Early Posthospitalization Mortality in Low Ejection Fraction Patients

  2022influential citation
• Multiparameter Monitoring with a Wearable Cardioverter Defibrillator

  2021cites this paper
• Analysis of Patients with LifeVest after Cardiac Surgery

  2020cites this paper
• International Journal of Innovative Technology and Exploring Engineering (IJITEE)

  2019cites this paper
• Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator

  2018cites this paper
• Electrical storm in the inflamed heart: ventricular tachycardia due to myocarditis

  2017cites this paper
• Digital Platforms in the Assessment and Monitoring of Patients with Bipolar Disorder

  2017cites this paper
• Guía ESC 2015 sobre el tratamiento de pacientes con arritmiasventriculares y prevención de la muerte súbita cardiaca

  2016cites this paper
• New horizon for infection prevention technology and implantable device

  2016cites this paper
• Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association

  2016cites this paper
• Bilateral Subclavian Vein Occlusion in a SAPHO Syndrome Patient Who Needed an Implantable Cardioverter Defibrillator.

  2016cites this paper
• Channelopathies - Emerging Trends in The Management of Inherited Arrhythmias

  2016cites this paper
• How should we use the wearable cardioverter-defibrillator in Japan?

  2014cites this paper
• Autonomous Device for Application in Late-Phase Hemorrhagic Shock Prevention

  2014cites this paper